Oct 23, 2014
             
Welcome 
Search  in  
Patient Site»
 
 
 
 
 Register Here  Username   Password    forgot password
 
      Updated: Oct 23, 2014 
Correlation between serum triglyceride level and clinical outcomes in STEMI who underwent a PCI   
Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Serum galectin-3 and insulin resistance: Correlation in patients with T2DM using a glucose clamp method   
Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus.
Impact of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han population   
Combination of higher level of uric acid and PPARGC1A (rs8192678) is an independent predictor for T2DM.
     
Beneficial impact of bezafibrate in patients with type 2 diabetes mellitus and dyslipidemia   
Bezafibrate improves insulin resistance in patients with type 2 diabetes mellitus.
Response of GLP-1 receptor agonist therapy in patients with type 2 diabetes   
GLP-1 receptor agonist therapy was significantly associated with treatment used before the initiation of therapy BMI and preprandial blood glucose level.
Correlation between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease   
Non-alcoholic fatty liver disease in association with non-alcoholic fatty liver disease, further increases the risk of cardiovascular events.
Correlation between epicardial adipose tissue inflammation and vitamin D deficiency   
Epicardial adipose tissue inflammation is related to vitamin D deficiency in patients affected by coronary artery disease.
Effectiveness of liraglutide and sitagliptin in type 2 diabetes in routine clinical practice   
Liraglutide shows superior glycaemic control and weight reduction than sitagliptin.
Do comorbidities impact pharmacotherapy of painful diabetic neuropathy in clinical practice   
Comorbidities like macroangiopathy, depression and pain characteristics may predict the effectiveness of duloxetine and anticonvulsants.
Correlation between hypoglycaemia and QT interval prolongation in T1DM   
Insulin induced hypoglycaemia may cause QTc prolongation in patients with T1DM.
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin in T2DM patients in the real world   
Exenatide decreases body weight by 3.5% while DPP-4 inhibitors by 1.0-1.5%.
Linking diabetes mellitus to platelet dysfunction in patients with ST-elevation myocardial infarction   
Mean platelet volume has good prognostic value for in-hospital and late mortality among both diabetics and non-diabetics.
Corneal nerve fiber length reduction in patients with type 1 or type 2 diabetes mellitus   
Extent of corneal nerve damage, may be influenced by type of diabetes and degree of neuropathy.
Correlation between oxidative stress and pro-inflammatory cytokines in diabetics with hyperglycemic crisis   
Oxidative stress and dysregulated serum pro-inflammatory cytokines are significantly increased in patients with hyperglycemic crises.
Underlying mechanism by which thiazolidinediones prevent the formation and progression of atherosclerosis and restenosis following percutaneous coronary intervention   
Pioglitazone modulates the proliferation and apoptosis of vascular smooth muscle cells via peroxisome proliferators-activated receptor-gamma.
Computerized algorithm versus conventional approach for glycemic control in patients undergoing cardiopulmonary bypass   
Early computer-based insulin therapy allows better achievement of normoglycemia in patients undergoing major cardiac surgery with the use of blood cardioplegia.
Association of abdominal fat distribution with atherosclerotic changes in the carotid artery   
Total fat area may be considered as a valuable measure of atherosclerotic changes.
Impact of liraglutide treatment and a calorie-restricted diet on lipoprotein profile in overweight/obese prediabetics   
Liraglutide therapy plus modest calorie restriction leads to enhanced weight loss and decrease in fasting plasma glucose concentration.
Predictive role of early postpartum HbA1c after pregnancy with gestational diabetes mellitus   
Increased HbA1c levels could be used as an indicator of risk for diabetes manifestation.
Differences in pancreatic volume, fat content, and fat density with duration of diabetes   
Pancreatic volume and fat deposition might be associated with T2D development and progression.
Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes   
Dapagliflozin had short-term tolerability profile, expected pharmacokinetic profiles and increased urinary glucose excretion in adults with type 1 diabetes.
Correlation between meat intake and indicators of insulin resistance and endothelial function in women   
Increased red meat intake is associated with abnormal glucose homeostasis in women.
Preventing metabolic disorders with telmisartan and indapamide in a high-normal blood pressure population   
Intervention with telmisartan and indapamide reduces the risk of metabolic syndrome.
Diabetes risk in patients treated with different HMG-CoA reductase inhibitors   
Pitavastatin shows the strongest effect on the development of new-onset diabetes.
Correlation between serum lipoprotein and cardiometabolic risk in middle-aged adults   
Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.
Association of hormone fibroblast growth factor 21 with epicardial fat thickness, metabolic parameters, and inflammatory markers in premenopausal obese women   
Epicardial fat, body mass index, and triglyceride are independent contributors of serum fibroblast growth factor 21 level in obese premenopausal women.
Kidney graft structure and function in T1DM patients with successful simultaneous pancreas and kidney transplantation versus live donor kidney transplantation alone   
In T1DM patients, simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone.
Effects of intrauterine glucose exposure on the newborn at birth and later in life   
The most significant predictor of developing IGT or type 2 diabetes is exposure to GDM.
The Basque Country Prospective Complications and Mortality Study risk engine (BASCORE)   
This validated population-derived model could predict 5-year fatal/non-fatal CHD and CVD risk in patients with newly diagnosed T2DM.
EURODIAB Prospective Complications Study: Impact of salt om outcomes in T1DM patients   
Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in patients with T1DM.
Correlation between resistance exercise and cardiovascular disease risk in women   
Rresistance exercise is associated with lower body fat, fasting glucose and total cholesterol.
Association of levels of irisin with cardio-metabolic variables and insulin sensitivity   
High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in nondiabetic adults.
Impact of left ventricular assist devices implantation on diabetic parameters in heart failure patients   
Mechanical circulatory support improves diabetic control in patients with advanced heart failure.
Correlation between circulating omega-6 polyunsaturated fatty acids and mortality   
High circulating linoleic acid, but not other n-6 PUFA, associated inversely with total and CHD mortality in older adults.
Cytomegalovirus seropositivity and risk of mortality from diabetes   
Cytomegalovirus infection may predict future mortality from diabetes in non-diabetic people.
Impact of maternal or fetal metformin concentrations on maternal glycemic control and neonatal outcome   
The degree of fetal metformin exposure does not influence fetal outcome in gestational diabetes mellitus.
Lipid Profiling for studying the therapeutic effects of metformin and glipizide in T2DM patients with coronary artery disease   
Therapeutic effects of metformin and glipizide are different in patients with type 2 diabetes and coronary artery disease.
Cardiometabolic profile in metabolically healthy obesity and metabolically abnormal obesity   
Cardiometabolic risk factors and inflammation in adipose tissue are increased in obese subjects classified as metabolically healthy.
Look AHEAD Trial: Bone Loss with intensive lifestyle intervention in patients with type 2 diabetes   
4-year weight loss intervention significantly and modestly increase bone loss at the hip in men but not in women.
Outcomes of empagliflozin treatment in patients with type 2 diabetes and hypertension   
Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.
Epidemiological Analysis of the ACCORD-MIND MRI Trial: Impact of Hypoglycemia on Brain Structure in T2DM   
Hypoglycemia related to T2DM treatment may not accentuate brain pathology, specifically brain atrophy or white matter abnormalities.
Association of frequency for glycated hemoglobin with diabetes control   
Quarterly monitoring leads to achievement of optimum downward trajectory in HbA1c, particularly in cases with suboptimal HbA1c.
Diabetes Prevention Program: Effects of Weight Loss, Weight Cycling, and Weight Loss Maintenance on Diabetes Incidence and Change in Cardiometabolic Traits   
Two-year weight loss was the strongest predictor of reduced diabetes risk and improvements in cardiometabolic traits.
DEFEND-1 Study: Low-dose otelixizumab anti-CD3 monoclonal antibody in recent-onset human type 1 diabetes   
Otelixizumab, at a dose of 3.1 mg is well tolerated in patients with recent-onset type 1 diabetes.
EDITION 1: New Insulin Glargine 300 Units/mL versus Glargine 100 Units/mL in T2DM patients on Basal and Mealtime Insulin   
Gla-300 can control HbA1c as well as Gla-100 in T2DM patients treated with basal and mealtime insulin, with consistently less risk of nocturnal hypoglycemia.
Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes   
Exenatide can be used as a noninsulin addition for patients failing basal insulin.
Controlling nocturnal hypertension in patients with type 2 diabetes mellitus   
Once-daily administration of antihypertensive drugs at bedtime may have favourable results in patients with type 2 diabetes mellitus and nocturnal hypertension.
Effect of metformin on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance   
Metformin therapy may yield some benefits to hyperprolactinaemic patients with coexisting glucose metabolism disturbances already receiving dopamine agonist therapy.
Efficacy and Safety of Remogliflozin Etabonate in patients with Type 2 Diabetes   
Administration of remogliflozin etabonate, twice daily demonstrates a dose-dependent improvement in glycemic control.
Cross-Sectional Analysis of ChildHeart and Health Study in England: Impact of Regular breakfast consumption on type 2 diabetes risk markers in 9- to 10-year-old children   
A more favourable type 2 diabetes risk profile is seen in children who ate breakfast daily, particularly a high fibre cereal breakfast.
Correlation between asymptomatic atrial fibrillation episodes and abnormalities of the autonomic nervous system among diabetics   
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes.
Role of diabetes mellitus and baseline coronary occlusion in AMI patients who underwent primary percutaneous coronary intervention   
In patients who underwent primary percutaneous coronary intervention, diabetes and baseline IRA occlusion, when present together, were associated with disproportionately higher rates of death and reinfarction.
Determinants of insulin-associated weight gain in type 2 diabetes mellitus   
Diabetes-related distress, insulin dose, and age contribute to insulin-associated weight gain in patients with type 2 diabetes.
Impact of frequency of physical activity on biomarkers of inflammation and insulin resistance in outpatients with coronary heart disease   
CRP, interleukin-6, and glucose are inversely associated with activity.
Betatrophin levels in newly diagnosed type 2 diabetic patients   
There is significant increase in circulating concentrations of betatrophin in T2DM patients.
Albiglutide versus Sitagliptin in patients with type 2 diabetes and renal impairment   
In renally impaired patients with type 2 diabetes, once-weekly administration of albiglutide therapy leads to statistically superior glycemic improvement with similar tolerability when compared with daily sitagliptin therapy.
Higher Gestational Weight Gain Is Associated With Increasing Offspring Birth Weight Independent of Maternal Glycemic Control in Women With Type 1 Diabetes   
Higher gestational weight gain in T1DM women is associated with increasing offspring birth weight.
Correlation of insulin requirements with adverse obstetric outcomes in women with preexisting diabetes   
In women with preexisting diabetes, falling insulin requirements are associated with an increased risk of complications related to placental dysfunction.
Metabolic syndrome in children  
The Harmonious Efficacy of Albiglutide as an Add-On therapy or Monotherapy for an Individualized T2DM Management  
Canagliflozin: The Blockbuster drug for the Co-morbid T2DM treatment  
Dapagliflozin: Clinical perspective   
Treatment and management of diabetic macular edema   
Gestational diabetes mellitus   
From trivial to extremely vital - The resurrection of Metabolic Syndrome for the present Diabetes management  
Lifestyle counseling in routine patient care  
  More..     
 

     

Fit2Me™, a Free Customized Diet and Lifestyle Support Program for T2DM patients launched by AstraZeneca    
Bayer Receives EU Approval for EYLEA┬« in Diabetic Macular Edema    
U.S. FDA approves INVOKAMET™ (canagliflozin/metformin HCl) for treating adults with type 2 diabetes    
Archive >>
     

IDF-WPR Congress 2014
Nov 21, 2014 - Nov 24, 2014.
Singapore


    

 


 
Featured Article

Insulin secretion from beta cells in intact mouse islets is targeted towards the vasculature



About Us  |  Disclaimer  |  Privacy Statement  |  Advertising info  |  Contact Us ©Copyright 2000-2014 Centrix Healthcare Inc - All Rights Reserved.